Evidence map›Paper›PMID 42352303›Full record

ArticleBiomolecules2026

Functional Group Chemistry Modulates Cellular Responses to Soluble Gelatin Derivatives Independent of Crosslinking.

Pekik Wiji Prasetyaningrum, Shinji Sakai

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pekik Wiji PrasetyaningrumDivision of Chemical Engineering, Department of Materials Engineering Science, Graduate School of Engineering Science, The University of Osaka, 1-3 Machikaneyama-cho, Toyonaka 560-8531, Osaka, Japan.ORCID 0000-0001-6075-9850
Shinji SakaiDivision of Chemical Engineering, Department of Materials Engineering Science, Graduate School of Engineering Science, The University of Osaka, 1-3 Machikaneyama-cho, Toyonaka 560-8531, Osaka, Japan.ORCID 0000-0002-1041-4798

Funding

Japan Science and Technology Agency JPMJTR234C
6 · The paper itself

Abstract

Gelatin functionalized with methacrylate (GelMA), norbornene (GelNB), and phenol (GelPH) has been studied as a precursor for crosslinkable biomaterials in tissue engineering. Cytocompatibility is usually assessed post-hydrogel formation, but cells briefly encounter soluble precursors during preparation and residual functional groups that may remain post-gelation. However, the biological effects of these uncrosslinked derivatives remain poorly understood. This study systematically investigated the impact of functional group chemistry on cellular responses under uncrosslinking conditions. Four cell lines, including fibroblasts (BALB/3T3), cervical cancer cells (HeLa), mesenchymal stem cells (UE7T-13), and neuronal cells (PC-12), were exposed to soluble GelMA, GelNB, and GelPH at matched polymer concentrations and degrees of functionalization (~50%). The results showed no overt cytotoxicity. The detectable differences were subtle and strongly cell type-dependent. HeLa and PC-12 cells showed no clear differences from untreated controls in most parameters. BALB/3T3 fibroblasts showed mainly GelMA-associated differences in mitochondrial activity, proliferation, and morphology. In the UE7T-13 cells, GelMA-treated cells showed the largest deviations from controls across the readouts examined, including mitochondrial activity, cell area, phenotype-related gene expression, and some osteogenic markers, while GelPH was intermediate and GelNB was comparable to controls. These findings underscore the importance of considering residual precursor effects in gelatin-based biomaterial design.

Indexed as

Cross-Linking ReagentsGelatinAnimalsBALB 3T3 CellsBiocompatible MaterialsCell ProliferationHeLa CellsHumansMesenchymal Stem CellsMicePC12 CellsRatsSolubilityBiocompatible MaterialsCross-Linking ReagentsGelatincytocompatibilitygelatinGelMAGelNBGelPH

Identifiers

PMID42352303
PMCPMC13297345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.